Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.

In a groundbreaking study published in BME Frontiers, researchers from the University of California, Los Angeles (UCLA), in collaboration with ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.

Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.

The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.